Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Provided By GlobeNewswire
Last update: Jun 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that members of management will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 3:20 p.m. ET.
Read more at globenewswire.com
